San DNAgo
Thanks to a fruitful partnership of academia and private enterprise, a vibrant biotech industry keeps on replicating itself.
San DNAgo
![[Facebook]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/facebook.png)
![[Google]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/google.png)
![[LinkedIn]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Twitter]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/twitter.png)
![[Email]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/email.png)
Previous post: Puncturing The ImClone Hype
Next post: Five Hurdles for Biotech
BiotechBlog’s Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Network and Share
Also from thinkBiotech
Translator
